Ashoo Gupta - 20 Dec 2025 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role
VP, Finance and Controller
Signature
/s/ Scott Bizily as Attorney-in-Fact for Ashoo Gupta
Issuer symbol
FDMT
Transactions as of
20 Dec 2025
Net transactions value
-$3,377
Form type
4
Filing time
23 Dec 2025, 21:05:45 UTC
Previous filing
10 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gupta Ashoo VP, Finance and Controller C/O 4D MOLECULAR THERAPEUTICS, INC., 5858 HORTON STREET #455, EMERYVILLE /s/ Scott Bizily as Attorney-in-Fact for Ashoo Gupta 23 Dec 2025 0002091461

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FDMT Common Stock Options Exercise +866 +1.9% 46,528 20 Dec 2025 Direct F1
transaction FDMT Common Stock Sale $2,691 -310 -0.67% $8.68 46,218 20 Dec 2025 Direct F2
transaction FDMT Common Stock Options Exercise +220 +0.48% 46,438 20 Dec 2025 Direct F1
transaction FDMT Common Stock Sale $686 -79 -0.17% $8.68 46,359 20 Dec 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDMT Restricted Stock Units Options Exercise $0 -866 -6.3% $0.000000 12,984 20 Dec 2025 Common Stock 866 Direct F1, F3
transaction FDMT Restricted Stock Units Options Exercise $0 -220 -6.2% $0.000000 3,308 20 Dec 2025 Common Stock 220 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units convert into common stock on a one-for-one basis.
F2 The transaction represents an automatic sale to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F3 The shares underlying the restricted stock unit award shall vest as to 25% of the shares on June 20, 2025 and as to 1/16th of the underlying shares on each quarterly anniversary of such date thereafter, while the grantee remains a service provider to the Company.
F4 The shares underlying the restricted stock unit award shall vest as to 1/16th of the shares on June 20, 2025 and as to 1/16th of the underlying shares on each quarterly anniversary of such date thereafter, while the grantee remains a service provider to the Company.